4 ms·
There aren’t many downsides at the moment because the safety is probably pretty ok and the efficacy is probably pretty decent, but the reality is that AstraZene
by addicted 6y ago
There aren’t many downsides at the moment because the safety is probably pretty ok and the efficacy is probably pretty decent, but the reality is that AstraZeneca completely botched their study and if this was not basically an emergency situation, the vaccine would not have been approved.
- MrAlex94 6y agoAstraZeneca did not conduct the study, Oxford did from the looks of it in relation to the half dose. The independent regulator was aware at every stage and recommended they continue with trying the half dose trial. [1](https://www.bbc.co.uk/news/health-55308216 https://www.bbc.co.uk/news/health-55308216).